Skip to content
Screener

Enovis ENOV Accrued Expenses

Accrued Expenses at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.48B
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$93.35M-8.9%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$334.3M-78.2%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$8.09M+14.5%
ESAB logo
ESABESAB
$82.04M+10.4%
OrthoPediatrics logo
OrthoPediatricsKIDS
$15.59M+16.4%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.4B-14.0%
Enterprise value$2.7B-9.5%
P/S0.6×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemJuly 3, 2026December 31, 2025
Accrued compensation and related benefits$96,123$105,112
Accrued taxes71,06527,178
Derivative liability – current portion48,04851,485
Accrued third-party commissions35,67938,174
Lease liability – current portion25,38024,742
Accrued rebates22,63531,033
Accrued professional fees13,73811,495
Accrued interest5,2124,193

Item 1. Financial Statements

FAQ

What is Enovis's accrued expenses?
Enovis (ENOV) reported accrued expenses of $96.12M in Q2 2026.
How has Enovis's accrued expenses changed year-over-year?
Enovis's accrued expenses increased by 14.5% year-over-year, from $83.93M to $96.12M.
What is the long-term trend for Enovis's accrued expenses?
Over 5 years (2020 to 2025), Enovis's accrued expenses has grown at a -25.4% compound annual growth rate (CAGR), from $454.33M to $105.11M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Enovis's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude